Combined telomerase inhibition and drug screen as novel therapies for tumor initiating cells in pediatric nervous system tumors.

结合端粒酶抑制和药物筛选作为小儿神经系统肿瘤肿瘤起始细胞的新疗法。

• 批准号: 192068
• 负责人: Tabori Uri
• 金额: $ 21.86万
• 依托单位: Hospital for Sick Children (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Salary Programs
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-09-01 至 2014-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=192068&lang=en
• 关键词: Brain Tumors; Neuroblastoma; Telomerase; Treatment; Tumor Initiating Cells

Tumor recurrence is still the most devastating event in childhood cancer. Although we can achieve minimal disease with our current aggressive therapies, some tumors tend to recur, eventually causing these children to succumb to their disease. Over the la

肿瘤复发仍然是儿童癌症中最具破坏性的事件。尽管我们可以通过 我们目前的积极治疗，一些肿瘤往往复发，最终导致这些孩子屈服于他们的 疾病 在洛杉矶